| Literature DB >> 19855951 |
Paul Arens1, Carmen Mansilla, Daniël Deinum, Laetitia Cavellini, André Moretti, Sophie Rolland, Hanneke van der Schoot, David Calvache, Fernando Ponz, Cécile Collonnier, René Mathis, Diederik Smilde, Carole Caranta, Ben Vosman.
Abstract
Molecular markers linked to phenotypically important traits are of great interest especially when traits are difficult and/or costly to be observed. In tomato where a strong focus on resistance breeding has led to the introgression of several resistance genes, resistance traits have become important characteristics in distinctness, uniformity and stability (DUS) testing for Plant Breeders Rights (PBR) applications. Evaluation of disease traits in biological assays is not always straightforward because assays are often influenced by environmental factors, and difficulties in scoring exist. In this study, we describe the development and/or evaluation of molecular marker assays for the Verticillium genes Ve1 and Ve2, the tomato mosaic virus Tm1 (linked marker), the tomato mosaic virus Tm2 and Tm2 ( 2 ) genes, the Meloidogyne incognita Mi1-2 gene, the Fusarium I (linked marker) and I2 loci, which are obligatory traits in PBR testing. The marker assays were evaluated for their robustness in a ring test and then evaluated in a set of varieties. Although in general, results between biological assays and marker assays gave highly correlated results, marker assays showed an advantage over biological tests in that the results were clearer, i.e., homozygote/heterozygote presence of the resistance gene can be detected and heterogeneity in seed lots can be identified readily. Within the UPOV framework for granting of PBR, the markers have the potential to fulfil the requirements needed for implementation in DUS testing of candidate varieties and could complement or may be an alternative to the pathogenesis tests that are carried out at present.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19855951 PMCID: PMC2807934 DOI: 10.1007/s00122-009-1183-2
Source DB: PubMed Journal: Theor Appl Genet ISSN: 0040-5752 Impact factor: 5.699
Primers used, amplification products and PCR conditions
| Pathogen and gene involved | Primer name | Sequence (5′–3′)a | Assay type | Amplification products (bp) | Origin of test | ||
|---|---|---|---|---|---|---|---|
| R-band | S-band | Other | |||||
|
| PMiF3 | GGTATGAGCATGCTTAATCAGAGCTCTC | SCAR co-dominant | 550 | 350 | Literature El Mehrach et al. ( | |
| PMiR3 | CCTACAAGAAATTATTGTGCGTGTGAATG | ||||||
| ToMV | SCN20F | GGTGCTCCGTCGATGCAAAGTGCA | SCAR dominant + LAT primersb | 1400 | – | 92 (Lat product) | Literature Ohmori et al. ( |
| SCN20R | GGTGCTCCGTAGACATAAAATCTA | ||||||
| ToMV | Outer primer TMV-2262F | GGGTATACTGGGAGTGTCCAATTC | Tetra primer ARMS co-dominant | 214 (Tm22) 255 (Tm2) | 417 | Primer design based on Lanfermeijer et al. ( | |
| Outer primer TMV-2678R | CCGTGCACGTTACTTCAGACAA | ||||||
| Tm22 SNP 2494F | CTCATCAAGCTTACTCTAGCCTACTTTA | ||||||
| Tm2 SNP2493 R | CTGCCAGTATATAACGGTCTAC | ||||||
| ToMV | Outer primer TM2-748F | CGGTCTGGGGAAAACAACTCT | Tetra primer ARMS co-dominant | 179 (Tm2 or Tm22) | 382 (tm2) | 509 | Primer design based on Lanfermeijer et al. ( |
| Outer primer TM2-1256R | CTAGCGGTATACCTCCACATCTCC | ||||||
| TM2- SNP901misR | GCAGGTTGTCCTCCAAATTTTCC | ||||||
| TM2- SNP901misF | CAAATTGGACTGACGGAACAGAAA | ||||||
|
| Outer primer Ve1_2072F | CCTTGATGGGGTTGATCTTTCGT | Tetra primer ARMS co-dominant | 476 | 158 | 580 | Sequence retrieval (based on Kawchuk et al. |
| Outer primer Ve1_2651R | GTAGGTGAGTTTCTTGGACAGTCGA | ||||||
| Ve1_SNP2199Ft | CAGGCCCTTTGGATGAATCAC | ||||||
| Ve1_SNP2199Ra | GTTGGACAAAAGAGAGAAAGTGAAGCT | ||||||
| Ve1_SNP2199F1tc | CAGGCCCTTTGGATGAATCACT | ||||||
| Ve1_SNP2199R1ac | GTTGGACAAAAGAGAGAAAGTGAAGCTTA | ||||||
|
| Outer primer Ve2_2720F | GGATCTTAGCTCACTTTATGTTTTGAAC | Tetra primer ARMS co-dominant | 242 | 131 | 321 | Sequence retrieval (based on Kawchuk et al. |
| Outer primer Ve2_3040R | GGTGCTGGTTTCAACTCTGAAGT | ||||||
| Ve2_SNP2827F | CAAATGCTTGAATCACTAGACCTGT | ||||||
| Ve2_SNP2827R | GGATCTCCCCGGACAGGTGG | ||||||
|
| At2-F3 | CGAATCTGTATATTACATCCGTCGT | SCAR dominant + LAT primersb | 130 | 92 (Lat product) | Literature on map position (Ori et al. | |
| At2-R3 | GGTGAATACCGATCATAGTCGAG | ||||||
|
| Z1063F | ATTTGAAAGCGTGGTATTGC | SCAR dominant + Rubisco primersd | 940 | 1380 (Rub product) | Primer design based on sequences Simons et al. ( | |
| Z1063R | CTTAAACTCACCATTAAATC | ||||||
aIn bold SNP-specific base, underlined base deliberately changed to create mismatch with template
bLat control primers: Lat1-F AGACCACGAGAACGATATTTGC, Lat2-R TTCTTGCCTTTTCATATCCAGACA
cSecond set of primers with deliberate mismatch closer to 3’-SNP end of primer gives better results at some laboratories
dRubisco control primers: Rub-F ATGTCACCACAAACAGAGAC, Rub-R CTCACAAGCAGCAGCTAG
Fig. 1Example of molecular assay: results of Verticillium assays on test set for robustness assessment (2% agarose). Varieties are Campeon, Marmande, Moneymaker, Persica, Kamonium and Chablis. a Ve1 assay: C control band (580 bp), R resistant allele (476 bp), S susceptible allele (158 bp) b Ve2 assay: C control band (321 bp), R resistant allele (242 bp), S susceptible allele (131 bp)
Overview of results in biological and molecular assays
| Test | Bioassay uncleara | Bio assay resultb | Molecular assay resultb | Overall result | ||
|---|---|---|---|---|---|---|
| R | S | R | S | Agreement/total | ||
| Verticillium | 4 | 36 | 9 | 36 | 9 | 43/45c |
| TMV | 2 | 39 | 10 | 39 | 10 | 49/49 |
| Mi | 4 | 26 | 21 | 26 | 21 | 47/47 |
| Fusarium I | 7 | 37 | 6 | 37 | 6 | 41/43c |
| Fusarium I2 | 5 | 36 | 9 | 37 | 8 | 44/45 |
aVarieties for which biological assay was unclear or inconsistent were analysed separately, see text
bOnly the varieties with conclusive biological test results
cOne variety was tested to be resistant using the bio assay, but was tested susceptible in the molecular assay; for one other variety, it was the other way about